TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Weatherford Int'l. (WFT) Stock Sliding Amid Lower Oil Prices
MARKETS

Neostem (NBS) Stock Declines After Pricing Secondary Public Offering

  • By Tony Owusu
  • May 28, 2015 12:59 PM EDT
3 Breakout Stocks Under $10 for Your Trading Radar
INVESTING

3 Breakout Stocks Under $10 for Your Trading Radar

  • By Roberto Pedone
  • Apr 23, 2015 1:58 PM EDT
Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie
STOCKS

Fifteen Fabulously Intelligent Biotech Stock Predictions for 2015

  • By Adam Feuerstein
  • Jan 6, 2015 11:52 AM EST
3 Basic Materials Stocks Driving The Sector Higher
MARKETS

Insider Trading Alert - UGI, NBS And MACK Traded By Insiders

  • By James Giaquinto
  • Dec 5, 2014 11:15 AM EST
3 Hold-Rated Dividend Stocks: GHL, OKS, OAK
MARKETS

Neostem (NBS): Today's Weak On High Volume Stock

  • By Marissa Goodbody
  • Nov 19, 2014 10:02 AM EST
Continental Resources (CLR) Stock Rises Today as Oil Prices Rally
MARKETS

NeoStem (NBS) Stock Plummets Today on Disappointing Cardiac Stem-Cell Therapy Data

  • By Andrew Meola
  • Nov 18, 2014 12:40 PM EST
'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
INVESTING

NeoStem's Stem Cell Therapy Fails Mid-Stage Heart Attack Study

  • By Adam Feuerstein
  • Nov 18, 2014 10:16 AM EST
Biotech Stock Mailbag: Grading 2015 Biotech Predictions at the Halfway Point
STOCKS

Super Important Biotech and Drug Stock Events for November

  • By Adam Feuerstein
  • Nov 3, 2014 8:24 AM EST
Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest
STOCKS

Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events

  • By Adam Feuerstein
  • Jul 14, 2014 9:30 AM EDT
MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales
STOCKS

Biotech Stock Mailbag: NeoStem, Gilead and the Importance of Big-Cap Biotech Earnings

  • By Adam Feuerstein
  • Apr 17, 2014 9:18 AM EDT
Dating Sites: Best, Worst & Weirdest
MARKETS

Why NeoStem (NBS) Stock Is Up Today

  • By Tony Owusu
  • Apr 14, 2014 3:57 PM EDT
'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
OPINION

Speculative Money Propels Biotechs La Jolla Pharma, Aeterna Zentaris

  • By Ciaran Thornton
  • Mar 11, 2014 4:31 PM EDT
4 Stocks Under $10 Making Big Moves
INVESTING

3 Biotech Stocks Under $10 to Trade for Breakouts

  • By Roberto Pedone
  • Feb 26, 2014 6:00 AM EST
Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie
STOCKS

Biotech Stock Mailbag: NeoStem, MannKind, Inovio

  • By Adam Feuerstein
  • Jan 10, 2014 6:00 AM EST
'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

22 Biotech Stock Predictions for 2014

  • By Adam Feuerstein
  • Jan 6, 2014 7:58 AM EST
4 Big-Volume Stocks to Trade for Breakouts: Crocs, Rovi and More
INVESTING

5 Stocks Under $10 Set to Soar

  • By Roberto Pedone
  • Dec 26, 2013 3:15 PM EST
Stem Cell Stocks Seek Comeback
VIDEO

Stem Cell Stocks Seek Comeback

  • By Gregg Greenberg
  • Dec 9, 2013 2:51 PM EST
Jim Cramer's 'Mad Money' Recap: Stocks on Sale
JIM CRAMER

Cramer's 'Mad Money' Recap: Preparing for the Worst

  • By Scott Rutt
  • Nov 28, 2012 7:59 PM EST
Stocks Will Correct by 10% to 15% in 2014 Even If New Highs Occur First
MARKETS

4 Biotech Stocks Under $10 Moving Higher

  • By Roberto Pedone
  • Oct 5, 2012 8:00 AM EDT
5 Bargain Bin Stocks to Buy in March
INVESTING

5 Stocks Under $10 Poised for Breakouts

  • By Roberto Pedone
  • Sep 7, 2012 11:49 AM EDT
Furiex Pharma Diarrhea Drug Produces Solid Results in Pivotal Studies
STOCKS

Biotech Stock Mailbag: Idenix Pharma

  • By Adam Feuerstein
  • Aug 19, 2011 6:40 AM EDT
Dating Sites: Best, Worst & Weirdest
INVESTING

Stem Cells, Foreign Stocks, BP's Next Challenge

  • By Gregg Greenberg
  • Jul 21, 2010 4:57 PM EDT
STOCKS

Biotech Stock Mailbag: Neostem

  • By Adam Feuerstein
  • May 28, 2010 7:00 AM EDT
Dating Sites: Best, Worst & Weirdest
OPINION

Stock Offerings: MGIC Investment

  • By Robert Holmes
  • Apr 20, 2010 11:07 AM EDT
Dating Sites: Best, Worst & Weirdest
STOCKS

Labopharm, China Direct: Early Volume Plays

  • By Robert Holmes
  • Feb 12, 2010 7:25 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.